Benitec Biopharma Inc (BNTC)

Apr 20, 2025

(BNTC) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 20, 2025

Apr 16, 2025

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha

Apr 15, 2025

Apr 12, 2025

JMP Securities Boosts Benitec Biopharma (NASDAQ:BNTC) Price Target to $20.00 - Defense World

Apr 12, 2025

Apr 11, 2025

Benitec Biopharma (BNTC) Stock Price Target Increased Amid Promi - GuruFocus

Apr 11, 2025

Apr 10, 2025

Benitec stock price target raised to $20 at JMP Securities - Investing.com Australia

Apr 10, 2025

Apr 10, 2025

Benitec stock price target raised to $20 at JMP Securities By Investing.com - Investing.com India

Apr 10, 2025

Apr 09, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Given Average Rating of “Buy” by Brokerages - Defense World

Apr 09, 2025

Apr 04, 2025

Q3 EPS Forecast for Benitec Biopharma Boosted by Analyst - Defense World

Apr 04, 2025

Apr 02, 2025

Suvretta capital management buys $211,736 in Benitec Biopharma shares By Investing.com - Investing.com Canada

Apr 02, 2025

Apr 02, 2025

Insiders Are Loving These 5 Tech and Biotech Stocks - 24/7 Wall St.

Apr 02, 2025

Apr 01, 2025

Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network

Apr 01, 2025

Apr 01, 2025

Top 5 Small-cap Biotech Stocks of 2025 - Nasdaq

Apr 01, 2025

Mar 31, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 900,000 Shares of Stock - MarketBeat

Mar 31, 2025

Mar 29, 2025

Benitec Biopharma completes stock and warrant offerings By Investing.com - Investing.com Australia

Mar 29, 2025

Mar 29, 2025

Suvretta capital purchases $11.7m in Benitec Biopharma shares By Investing.com - Investing.com India

Mar 29, 2025

Mar 28, 2025

Major Investment Alert: Benitec Biopharma Stock Purchase Shakes the Market! - TipRanks

Mar 28, 2025

Mar 28, 2025

Benitec Biopharma completes stock and warrant offerings - Investing.com India

Mar 28, 2025

Mar 28, 2025

Suvretta capital purchases $11.7m in Benitec Biopharma shares - Investing.com

Mar 28, 2025

Mar 27, 2025

Benitec Biopharma inks deal granting stock resale rights - Investing.com India

Mar 27, 2025

Mar 27, 2025

Benitec Biopharma inks deal granting stock resale rights By Investing.com - Investing.com Canada

Mar 27, 2025

Mar 26, 2025

Benitec Biopharma prices $30M securities offerings - MSN

Mar 26, 2025

Mar 26, 2025

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewswire

Mar 26, 2025

Mar 25, 2025

Benitec Biopharma prices 1.44M shares at $13.00 in underwritten offering - TipRanks

Mar 25, 2025

Mar 25, 2025

Benitec Biopharma Prices $30 Million Equity Offerings - MarketScreener

Mar 25, 2025

Mar 25, 2025

(BNTC) Trading Report - news.stocktradersdaily.com

Mar 25, 2025

Mar 25, 2025

Benitec Biopharma (NASDAQ:BNTC) Receives Buy Rating from HC Wainwright - Defense World

Mar 25, 2025

Mar 24, 2025

H.C. Wainwright maintains Buy on Benitec BioPharma stock By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

H.C. Wainwright maintains Buy on Benitec BioPharma stock - Investing.com

Mar 24, 2025

Mar 21, 2025

Micron Technology, Nike, FedEx And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Mar 21, 2025

Mar 21, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 21, 2025

Mar 21, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Up 17.6% in February - Defense World

Mar 21, 2025

Mar 20, 2025

Benitec Biopharma stock soars to 52-week high of $16.2 By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Benitec Biopharma stock soars to 52-week high of $16.2 - Investing.com

Mar 20, 2025

Mar 19, 2025

Benitec reports progress in OPMD swallowing function study By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Benitec Biopharma Reports Positive Interim Results For BB-301 Gene Therapy In OPMD Clinical Trial - RTTNews

Mar 19, 2025

Mar 19, 2025

Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com

Mar 19, 2025

Mar 19, 2025

Benitec Biopharma Announces Positive Interim Results for BB-301 - TipRanks

Mar 19, 2025

Mar 19, 2025

Benitec reports progress in OPMD swallowing function study - Investing.com India

Mar 19, 2025

Mar 19, 2025

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - The Manila Times

Mar 19, 2025

Mar 19, 2025

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with ... - The Bakersfield Californian

Mar 19, 2025

Mar 19, 2025

Benitec Biopharma Reports Positive Interim Clinical Results - GlobeNewswire

Mar 19, 2025

Mar 18, 2025

Benitec stock holds $18 target, Market Outperform rating By Investing.com - Investing.com UK

Mar 18, 2025

Mar 15, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Mar 15, 2025